CRK-Associated Substrate Lymphocyte Type Regulates Transforming Growth Factor-Β Signaling by Inhibiting Smad6 and Smad7

Oncogene - United Kingdom
doi 10.1038/sj.onc.1209848
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Syndecan-2 Regulates Transforming Growth Factor-Β Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

miR-140-5p Regulates Adipocyte Differentiation by Targeting Transforming Growth Factor-Β Signaling

Scientific Reports
Multidisciplinary
2015English

Targeting Transforming Growth Factor-Β Signaling

Current Opinion in Oncology
Cancer ResearchOncology
2007English

Smad7 Inhibits Transforming Growth Factor-Β Family Type I Receptors Through Two Distinct Modes of Interaction

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling Through an Interaction With the TGF-β Type I Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor Beta Signaling

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

HTLV-I Tax Induces and Associates With CRK-Associated Substrate Lymphocyte Type (Cas-L)

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

Transforming Growth Factor Β

2017English

Transforming Growth Factor-Β

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy